Closed-loop EEG study on visual recognition during driving.

Objective.In contrast to the classical visual brain-computer interface (BCI) paradigms, which adhere to a rigid trial structure and restricted user behavior, electroencephalogram (EEG)-based visual recognition decoding during our daily activities remains challenging. The objective of this study is to explore the feasibility of decoding the EEG signature of visual recognition in experimental conditions promoting our natural ocular behavior when interacting with our dynamic environment.Approach.In our experiment, subjects visually search for a target object among suddenly appearing objects in the environment while driving a car-simulator. Given that subjects exhibit an unconstrained overt visual behavior, we based our study on eye fixation-related potentials (EFRPs). We report on gaze behavior and single-trial EFRP decoding performance (fixations on visually similar target vs. non-target objects). In addition, we demonstrate the application of our approach in a closed-loop BCI setup.Main results.To identify the target out of four symbol types along a road segment, the BCI system integrated decoding probabilities of multiple EFRP and achieved the average online accuracy of 0.37 ± 0.06 (12 subjects), statistically significantly above the chance level. Using the acquired data, we performed a comparative study of classification algorithms (discriminating target vs. non-target) and feature spaces in a simulated online scenario. The EEG approaches yielded similar moderate performances of at most 0.6 AUC, yet statistically significantly above the chance level. In addition, the gaze duration (dwell time) appears to be an additional informative feature in this context.Significance.These results show that visual recognition of sudden events can be decoded during active driving. Therefore, this study lays a foundation for assistive and recommender systems based on the driver's brain signals.

Spatial covariance improves BCI performance for late ERPs components with high temporal variability.

OBJECTIVE: Event Related Potentials (ERPs) reflecting cognitive response to external stimuli, are widely used in brain computer interfaces. ERP waveforms are characterized by a series of components of particular latency and amplitude. The classical ERP decoding methods exploit this waveform characteristic and thus achieve a high performance only if there is sufficient time- and phase-locking across trials. The required condition is not fulfilled if the experimental tasks are challenging or if it is needed to generalize across various experimental conditions. Features based on spatial covariances across channels can potentially overcome the latency jitter and delays since they aggregate the information across time. APPROACH: We compared the performance stability of waveform and covariance-based features as well as their combination in two simulated scenarios: 1) generalization across experiments on Error-related Potentials and 2) dealing with larger latency jitter across trials. MAIN RESULTS: The features based on spatial covariances provide a stable performance with a minor decline under jitter levels of up to ± 300 ms, whereas the decoding performance with waveform features quickly drops from 0.85 to 0.55 AUC. The generalization across ErrP experiments also resulted in a significantly more stable performance with covariance-based features. SIGNIFICANCE: The results confirmed our hypothesis that covariance-based features can be used to: 1) classify more reliably ERPs with higher intrinsic variability in more challenging real-life applications and 2) generalize across related experimental protocols.

Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits.

Rivastigmine has been shown to improve cognition in HIV+ patients with minor neurocognitive disorders; however, the mechanisms underlying such beneficial effect are currently unknown. To assess whether rivastigmine therapy is associated with decreased brain inflammation and damage, we performed T1/T2* relaxometry and magnetization transfer imaging in 17 aviremic HIV+ patients with minor neurocognitive disorders enrolled on a crossed over randomized rivastigmine trial. Rivastigmine therapy was associated with changes in MRI metrics indicating a decrease in brain water content (i.e., edema reabsorption) and/or reduced demyelination/axonal damage. Furthermore, MRI changes correlated with cognitive improvement on rivastigmine therapy.